FDA Approves First-Ever Needle-Free Insulin For Kids 6 And Older

FDA Approves First-Ever Needle-Free Insulin For Kids 6 And Older The FDA expanded the approved use for the inhaled insulin drug Afrezza on Friday. ABC News reports it is now approved for kids 6 years and older with Type 1 diabetes or those who require insulin with Type 2 diabetes. Plus: AI use as a diagnostic tool; Massachusetts vs. UnitedHealthcare in alleged Medicaid fraud case; and more. https://kffhealthnews.org/morning-breakout/pharma-6/